Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
About Us
Media Contact
Frequently Asked Questions
Media Site Map

CDC News
Press Release Library
Transcripts
MMWR Summaries
B-Roll Footage
Upcoming Events

Related Links
Centers at CDC
Data and Statistics
Health Topics A-Z
Image Library
Publications, Software and Other Products
Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


MMWR
Synopsis for September 22, 2000

MMWR articles are embargoed until 4 p.m. E.S.T. Thursdays.

  1. Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999 and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999
  2. State-Specific Changes in Singleton Preterm Births Among Black and White Women United States, 1990 and 1997
 

MMWR
Synopsis for September 22, 2000

Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999 and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999

As drug-resistant strains of gonorrhea continue to emerge, successful treatment of this sexually transmitted disease is becoming more difficult.

 
PRESS CONTACT:
Office of Communications

CDC, National Center for HIV, STD and TB Prevention
(404) 6398895
 

In the 1980s, penicillin and tetracycline became ineffective for treatment of gonorrhea due to resistance. Two fluoroquinolone antibiotics - ciprofloxacin and ofloxacin - have been recommended by CDC as treatments for gonorrhea since 1989. High levels of fluoroquinolone-resistant gonorrhea are now being reported in Hawaii, where it increased from 1.4% of strains tested in 1997 to 9.5% in 1999. Consequently, CDC recommends that health care providers ask patients with gonorrhea if they or their sex partners could have acquired the disease in Hawaii, other Pacific Islands, or Asia, where fluoroquinolone-resistant gonorrhea is common. If so, patients should be treated with cefixime or ceftriaxone, which are other drugs that are currently recommended for treating gonorrhea, and to which no resistance has been reported.

 

State-Specific Changes in Singleton Preterm Births Among Black and White Women United States, 1990 and 1997

The racial gap in preterm delivery rates is narrowing, but black women still have about double the rate of preterm births as do white women.

 
PRESS CONTACT:
Willie Parker, M.D., M.P.H.

California Department of Health
(770) 4885187
Atlanta, GA
Alternate:
Vijaya Hogan, CDC

(916) 6570324
Sacramento, CA
 

Preterm singleton deliveries to non-Hispanic black women declined between 1990 and 1997 in many states, confirming a previously reported national trend in the rate of preterm (premature) deliveries. The national preterm delivery rate for black women fell 9.8 % from 178.5 per 1000 live births in 1990 to 160.9 in 1997. Preterm singleton births to black women declined in 24 states during that period. Despite this improvement, racial disparities persist: twice as many black women have preterm deliveries, compared with non-Hispanic white women. In contrast with the improved rates for black women, the national rate of preterm singleton deliveries to non-Hispanic white women increased 11% during the period of 1990-1997, from 75.4 per 1000 live births to 83.7.


 

Media Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed September 22, 2000
URL:

Centers for Disease Control and Prevention
Office of Communication